Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Trial Profile

Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs LOAd 703 (Primary)
  • Indications Adenocarcinoma; Biliary cancer; Colorectal cancer; Fallopian tube cancer; Ovarian cancer; Pancreatic cancer; Peritoneal cancer
  • Focus Adverse reactions
  • Sponsors Lokon Pharma
  • Most Recent Events

    • 24 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top